Airware Labs Launches Product Sales in Canada

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--

Airware Labs Corporation AIRW today announced Katz Group Pharmacies Inc. will offer AIR^™ ALLERGY, AIR^™ SLEEP SNORE, AIR^™ DECONGEST and AIR^™ BREATHE at 460 retail pharmacies across Central and Western Canada. Katz Group is one of Canada's largest privately owned enterprises with pharmacy operations that include convenient Rexall and Rexall Pharma Plus locations in Canada.

According to Airware Labs CEO Jeffrey Rassas, "Smog in Canada has been found to be a contributing factor to premature deaths across the country as well as increased hospital and doctor visits. At the same time, the number of allergy suffers have continued to rise with some doctors estimating one in four Canadians now suffer with allergic rhinitis, while another 8 per cent of adults and 12 per cent of children struggle with asthma. We are delighted to work with the Katz Group to bring our pioneering products to leading pharmacies across the country and provide consumers in Canada access to effective, innovative solutions to challenging health concerns and common health problems like allergies, snoring, and congestion."

Airware Labs' products are marketed under the brand name of AIR^™ and include over-the-counter consumer-facing products that address airborne bacteria and viruses, allergies, congestion, snoring, insomnia, nausea, headaches, and enhanced sports performance. Unlike external products such as strips, these soft, comfortable, and discreet, latex and drug free products fit just inside the nose utilizing an FDA approved medical grade material. Nearly invisible for use anytime and anywhere, the AIR^™ products' microstructure enhances normal nasal airflow with every breath and is clinically proven to deliver up to 40% more oxygen. Some Airware products include 3M filtration media to stop allergens, airborne bacteria and viruses as well as a blend of proven, therapeutic premium oils to provide additional antimicrobial protection and symptomatic relief.

With its entrance into Canadian markets, Airware Labs is continuing its progress in aggressively pursuing efforts that advance the company's retail presence in domestic and international markets, while building brand awareness among consumers through partnerships that provide access to high profile, consumer-favored brick and mortar and online prominent retail outlets. "We have a high degree of confidence in our continuing efforts to grow market opportunities that will allow us to reach consumers with important messages that resonate. We expect our expanding market presence to ignite prospects for continued growth. We continue to believe that consumers will seek out affordable products that offer innovative, drug-free solutions to prominent health issues impacting them and their families," said Rassas.

Today's announcement of Airware Labs expansion into Canadian markets follows recent announcements of the company's international expansion into India as well as its domestic expansion into Winn Dixie and BI-LO stores across the country. Airware Labs' products are also available in the U.S. through a number of other consumer-preferred retail locations including Walgreens, Albertsons, Acme, Shoppers, Shop n' Save, ACME, and Farm Fresh along with individual distributors in the United States, Canada, and Europe. Online the products are available at a variety of popular retail sites including Walmart, Walgreen's, Target, Drugstore.com, CVS, Amazon and Airware Labs.

About Airware Labs Corporation: Airware Labs Corp. (publicly traded as OTCQB: AIRW) provides patented, innovative breathing technology products that promote better health and enhanced wellbeing in addition to a new line of skin care products. The company is headquartered in Scottsdale, Arizona. Explore our extensive product line at http://www.airwarelabs.com and learn more about our company by visiting http://airwarelabscorp.com.

Forward-Looking Statement: The statements in this press release regarding any implied or perceived benefits from the release by Airware Labs Corp. of its products are forward-looking statements. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.